Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

EPA:BON - Euronext Paris - Matif - FR0000063935 - Common Stock - Currency: EUR

7.1  -0.33 (-4.44%)

Fundamental Rating

3

Taking everything into account, BON scores 3 out of 10 in our fundamental rating. BON was compared to 58 industry peers in the Food Products industry. BON has a bad profitability rating. Also its financial health evaluation is rather negative. BON is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BON has reported negative net income.
BON had a negative operating cash flow in the past year.
BON had positive earnings in 4 of the past 5 years.
BON had a positive operating cash flow in 4 of the past 5 years.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

BON's Return On Assets of -6.18% is on the low side compared to the rest of the industry. BON is outperformed by 82.76% of its industry peers.
BON's Return On Equity of -18.71% is on the low side compared to the rest of the industry. BON is outperformed by 82.76% of its industry peers.
BON has a Return On Invested Capital (4.79%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BON is below the industry average of 7.10%.
The last Return On Invested Capital (4.79%) for BON is above the 3 year average (3.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.18%
ROE -18.71%
ROIC 4.79%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Operating Margin, with a value of 3.17%, BON is doing worse than 65.52% of the companies in the same industry.
In the last couple of years the Operating Margin of BON has declined.
The Gross Margin of BON (28.32%) is worse than 68.97% of its industry peers.
BON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.17%
PM (TTM) N/A
GM 28.32%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

BON has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BON remains at a similar level compared to 1 year ago.
BON has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BON has a worse debt to assets ratio.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

BON has an Altman-Z score of 2.08. This is not the best score and indicates that BON is in the grey zone with still only limited risk for bankruptcy at the moment.
BON has a Altman-Z score of 2.08. This is comparable to the rest of the industry: BON outperforms 48.28% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that BON is somewhat dependend on debt financing.
BON has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: BON underperforms 63.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 2.08
ROIC/WACC0.96
WACC5.01%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.28 indicates that BON should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.28, BON is in line with its industry, outperforming 44.83% of the companies in the same industry.
A Quick Ratio of 0.41 indicates that BON may have some problems paying its short term obligations.
The Quick ratio of BON (0.41) is worse than 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.41
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

BON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -983.72%.
BON shows a decrease in Revenue. In the last year, the revenue decreased by -1.43%.
Measured over the past years, BON shows a decrease in Revenue. The Revenue has been decreasing by -3.11% on average per year.
EPS 1Y (TTM)-983.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2095.08%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-0.36%

3.2 Future

The Earnings Per Share is expected to grow by 23.09% on average over the next years. This is a very strong growth
BON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.07% yearly.
EPS Next Y1.9%
EPS Next 2Y21.28%
EPS Next 3Y23.09%
EPS Next 5YN/A
Revenue Next Year-2.72%
Revenue Next 2Y-0.52%
Revenue Next 3Y0.48%
Revenue Next 5Y2.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 7.95, the valuation of BON can be described as very cheap.
BON's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BON is cheaper than 79.31% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. BON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.95
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than BON, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.56
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BON does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BON's earnings are expected to grow with 23.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.28%
EPS Next 3Y23.09%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.69%, BON has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.37, BON has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, BON has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of BON are negative and hence is the payout ratio. BON will probably not be able to sustain this dividend level.
DP-6.9%
EPS Next 2Y21.28%
EPS Next 3Y23.09%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

More info and screens

BONDUELLE SCA

EPA:BON (3/7/2025, 7:00:00 PM)

7.1

-0.33 (-4.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-05 2025-03-05
Earnings (Next)05-06 2025-05-06
Inst Owners6.51%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap231.67M
Analysts78
Price Target8.93 (25.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.08%
PT rev (3m)-2.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.89%
EPS NY rev (3m)-10.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.04%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.95
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.7
EV/EBITDA 2.56
EPS(TTM)-3.74
EYN/A
EPS(NY)0.89
Fwd EY12.58%
FCF(TTM)-2.99
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS72.69
BVpS19.62
TBVpS10.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.18%
ROE -18.71%
ROCE 6.77%
ROIC 4.79%
ROICexc 4.86%
ROICexgc 6.67%
OM 3.17%
PM (TTM) N/A
GM 28.32%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA 1.51
Cap/Depr 40.47%
Cap/Sales 3.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.41
Altman-Z 2.08
F-Score4
WACC5.01%
ROIC/WACC0.96
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-983.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2095.08%
EPS Next Y1.9%
EPS Next 2Y21.28%
EPS Next 3Y23.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-0.36%
Revenue Next Year-2.72%
Revenue Next 2Y-0.52%
Revenue Next 3Y0.48%
Revenue Next 5Y2.07%
EBIT growth 1Y14.29%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1267.64%
EBIT Next 3Y149.65%
EBIT Next 5Y75.84%
FCF growth 1Y-31.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-435.2%
OCF growth 3YN/A
OCF growth 5YN/A